Nonprofit · EIN 20-3186261
SOCIETY FOR TRANSLATIONAL ONCOLOGY INC
Tax-exempt · DURHAM, NC 27701
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $289,410 | $536,505 | -$247,095 | $1,266,853 | $67,642 | $1,199,211 |
| December 31, 2024 | 990 | $476,537 | $503,387 | -$26,850 | $1,476,634 | $65,042 | $1,411,592 |
| December 31, 2023 | 990 | $467,002 | $722,531 | -$255,529 | $1,525,997 | $118,825 | $1,407,172 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $166,453
- Program service revenue
- $0
- Investment income
- $47,740
- Net gain from sales of assets
- -$3,084
- Other revenue
- $75,217
Expenses
- Grants and similar amounts paid
- $1,563
- Other salaries and wages
- $262,453
- Salaries, compensation and benefits (total)
- $312,390
- Professional fundraising fees
- $0
- Legal fees
- $2,305
- Accounting fees
- $45,753
- Travel
- $45,180
- Depreciation
- $168
- Program services (functional)
- $212,337
- Management and general (functional)
- $324,168
Balance sheet and other
- Total assets, start of year
- $1,476,634
- Total assets, end of year
- $1,266,853
- Total liabilities, end of year
- $67,642
- Net assets, end of year
- $1,199,211
- Net assets without donor restrictions
- $314,657
- Net assets with donor restrictions
- $884,554
- Gross receipts
- $907,153
- Employees
- 4
- Volunteers
- 32
- Year formed
- 2000
- State of legal domicile
- NC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Ann Murphy PHD | Executive Director Trustee or director, Officer | 1 | $0 |
| Martin J Murphy DMEDSC PHD FASCO | Chairman Trustee or director, Officer | 1 | $0 |
| Kenneth B Lee MBA | Treasurer Trustee or director, Officer | 1 | $0 |
| Sean Khozin MD MPH | Director Trustee or director | 1 | $0 |
| Ke Liu MD PHD | Director Trustee or director | 1 | $0 |
| Mace L Rothenberg MD FACP | Director Trustee or director | 1 | $0 |
| Lillian L Siu MD FRCPC FASCO | Director Trustee or director | 1 | $0 |
990 for the year ended December 31, 2024: 7 people
| Name | Title | Hours / week | Compensation | From related orgs |
|---|---|---|---|---|
| Ann Murphy PHD | Executive Director Trustee or director, Officer | 1 | $0 | $43,764 |
| Martin J Murphy DMEDSC PHD FASCO | Chairman Trustee or director, Officer | 1 | $0 | $0 |
| Kenneth B Lee MBA | Treasurer Trustee or director, Officer | 1 | $0 | $0 |
| Sean Khozin MD MPH | Director Trustee or director | 1 | $0 | $0 |
| Ke Liu MD PHD | Director Trustee or director | 1 | $0 | $0 |
| Mace L Rothenberg MD FACP | Director Trustee or director | 1 | $0 | $0 |
| Lillian L Siu MD FRCPC FASCO | Director Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 7 people
| Name | Title | Hours / week | Compensation | From related orgs |
|---|---|---|---|---|
| Ann Murphy PHD | Executive Director Trustee or director, Officer | 1 | $0 | $125,122 |
| Martin J Murphy DMEDSC PHD FASCO | Chairman Trustee or director, Officer | 1 | $0 | $0 |
| Kenneth B Lee MBA | Treasurer Trustee or director, Officer | 1 | $0 | $0 |
| Sean Khozin MD MPH | Director Trustee or director | 1 | $0 | $0 |
| Ke Liu MD PHD | Director Trustee or director | 1 | $0 | $0 |
| Mace L Rothenberg MD FACP | Director Trustee or director | 1 | $0 | $0 |
| Lillian L Siu MD FRCPC FASCO | Director Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 280 S MANGUM ST STE 350, DURHAM, NC 27701-3681
- In care of
- % TECHCXO
- Principal officer (990 for 2025)
- Kenneth Lee, PO Box 12412, Durham, NC 27709
- Signed the 990
- Kenneth Lee, Treasurer
- Phone
- (919) 641-5323
- Website
- WWW.STO-ONLINE.ORG
- Return prepared by
- Hoelting & Company Inc
Mission
See Schedule O
Program accomplishments
- HARMONY is a global initiative advancing equitable cancer care by improving alignment across clinical research, regulatory pathways and implementation. In response to persistent disparities in access to cancer prevention, screening and treatment, HARMONY convenes international stakeholders to reduce fragmentation, strengthen collaboration and accelerate the translation of evidence into practice. Current activities focus on cervical cancer, a largely preventable disease that causes disproportionate mortality in low-resource and underserved settings. HARMONY supports harmonized approaches to clinical trials and implementation research, promotes equitable access to evidence-based interventions (HPV screening and early detection), and builds collaborative networks to advance sustainable, scalable solutions. Collectively, these efforts aim to ensure that innovations in cervical cancer prevention and care reach populations most at risk and contribute to global elimination goals.Expenses $87,207
- Molecular testing is a foundational element of personalized medicine. Understanding and overcoming challenges in implementing best practice guidelines for molecular testing can support better diagnosis and guide treatment decisions. "Incorporating Molecular Testing to Support Personalized Cancer Care" is a three-part educational program that focuses on the adoption of best practice guidelines and incorporating evidence from an MD Anderson Cancer Network Performance Improvement and Quality Improvement (PI/QI) program (a program of The University of Texas MD Anderson Cancer Center). Piloted at two Cancer Network sites, this PI/QI program aimed to optimize the use of molecular testing in thyroid and lung cancers.Expenses $38,818
- The Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization that promotes high-quality, equitable patient care and fosters the discovery and clinical translation of important new therapies that enhance the practice of global oncology as well as supports the prevention and treatment of infectious diseases that impact cancer patients and others with weakened immune systems, thus helping protect the vulnerable from life-threatening infections. STO bridges a translational gap between drug discovery and approved drug delivery with a portfolio of educational activities for physicians and other members of the healthcare team. STO's decades-long commitment to translational research and education includes fellowships in both cancer and infectious diseases. The latter has become a critical STO commitment during the COVID-19 pandemic from the global genesis to worldwide distribution of new vaccines and improved therapeutics. STO is committed to diversity, inclusivity, and equity throughout our programs.Expenses $86,312 · grants $1,563
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-3186261
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2009
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H30)
- Assets (IRS master file)
- $1,266,853
- Income (IRS master file)
- $907,153
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $289,410 | $536,505 | $1,266,853 | IRS |
| 990 | December 2024 | $476,537 | $503,387 | $1,476,634 | XML |
| 990 | December 2023 | $467,002 | $722,531 | $1,525,997 | XML |
| 990 | December 2022 | $1,410,812 | $885,287 | $1,832,539 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-3186261).
Questions about SOCIETY FOR TRANSLATIONAL ONCOLOGY INC
- What is the EIN of SOCIETY FOR TRANSLATIONAL ONCOLOGY INC?
- The employer identification number (EIN) of SOCIETY FOR TRANSLATIONAL ONCOLOGY INC is 20-3186261.
- Is SOCIETY FOR TRANSLATIONAL ONCOLOGY INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2009.
- Are donations to SOCIETY FOR TRANSLATIONAL ONCOLOGY INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does SOCIETY FOR TRANSLATIONAL ONCOLOGY INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of SOCIETY FOR TRANSLATIONAL ONCOLOGY INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did SOCIETY FOR TRANSLATIONAL ONCOLOGY INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of SOCIETY FOR TRANSLATIONAL ONCOLOGY INC?
- The 990 for the year ended December 31, 2025 names Kenneth Lee.
- Who are the officers and directors of SOCIETY FOR TRANSLATIONAL ONCOLOGY INC?
- The 990 for the year ended December 31, 2025 lists 7 people; 0 received compensation from the organization.
- How much revenue does SOCIETY FOR TRANSLATIONAL ONCOLOGY INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $289,410, expenses of $536,505 and total assets of $1,266,853 at year end.
Other nonprofits in DURHAM
- CHORDOMA FOUNDATION EIN 20-8423943 · last filed 990 for 2025
- GLIOBLASTOMA FOUNDATION INC EIN 81-2849764 · last filed 990 for 2024
- RARE CANCER RESEARCH FOUNDATION EIN 46-3405526 · last filed 990 for 2025
- DUKE MEDICINE GLOBAL SUPPORT CORP EIN 61-1593721 · last filed 990 for 2025
- VOA FOUNDATION EIN 88-1907540 · last filed 990-EZ for 2025
- INTERNATIONAL CANCER CARE & RESEARCH EXCELLENCE FOUNDATION INC EIN 47-3821684 · last filed 990-EZ for 2025
- WPLAB INC EIN 86-1413357 · last filed 990 for 2025
- CHAMP FOUNDATION EIN 47-5555752 · last filed 990 for 2024
All nonprofits in DURHAM · North Carolina · Medical research